Late-stage clinical mRNA medicines company Arcturus Therapeutics Holdings Inc (Nasdaq: ARCT) announced on Monday that it has received Orphan Drug Designation from the U.S. FDA for ARCT-032 in cystic fibrosis (CF) treatment.
The designation offers incentives, including potential market exclusivity for seven years upon FDA approval. The Phase 1b study's first CF patient completed two administrations of ARCT-032, with interim Phase 1b data expected in H1 2024.
CF is a globally distributed life-shortening disease caused by mutations in the CFTR gene. ARCT-032 utilises Arcturus' LUNAR lipid-mediated aerosolised platform to deliver CFTR messenger RNA to the lungs, potentially restoring CFTR activity.
Arcturus was founded in 2013 and is based in San Diego. It has various enabling technologies, including LUNAR lipid-mediated delivery and STARR mRNA Technology. The pipeline includes candidates for ornithine transcarbamylase deficiency and cystic fibrosis, along with mRNA vaccine programs for COVID-19 and influenza.
Renew Biotechnologies names new chief operating officer
Teva, Sanofi accelerate inflammatory bowel disease drug trial
Ro adds David B Allison to Advisory Board
Charles River Laboratories and Autobahn Labs forge alliance to boost academic drug discovery
Nkarta partnering with Columbia on investigator-led lupus trial for NKX019
Gilead's lenacapavir demonstrates 100% efficacy in HIV prevention trial
Anixa Biosciences' ovarian cancer CAR-T therapy individual patient IND receives FDA approval
Evergreen Nephrology names new director
Emmaus Life Sciences names new chief executive officer
FDA feedback boosts Diamyd Medical's pathway to accelerated approval for Type 1 Diabetes Therapy
TC BioPharm (Holdings) doses sixth patient in TCB-008 clinical trial
Caidya names new chief executive officer
Ionis Pharmaceuticals reports positive results for ION582 in Angelman syndrome study
Nuvalent launches HEROEX-1 trial for HER2-selective inhibitor NVL-330
Astellas and Osaka University collaborate on stem cell therapy for disc degeneration